BackKiniksa Pharmaceuticals International Plc. Overview
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A

Kiniksa Pharmaceuticals International Plc. Target Price

Analysts' average 12-month price target for Kiniksa Pharmaceuticals International Plc. is $85.

Get informed when a big investor buys or sells

+ Follow

Share Price

$75.08

Average Target Price

$84.6712.8% upside

6 analysts in the last 4 months

High: $99 | Low: $72

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30Goldman SachsPaul Choi$9019.9% upsideOpen
2026-07-29Wedbush$9931.9% upsideOpen
2026-07-29Canaccord GenuityEdward Nash$9830.5% upsideOpen
2026-07-23Goldman SachsPaul Choi$750.1% downsideOpen
2026-07-13Wells Fargo$741.4% downsideOpen
2026-06-29Wedbush$724.1% downsideOpen
2026-04-29Wedbush$5921.4% downsideOpen
2026-04-28JefferiesRoger Song$715.4% downsideOpen
2026-04-16Wedbush$5822.7% downsideOpen
2026-02-19Canaccord Genuity$6217.4% downsideOpen
2026-01-13WedbushDavid Nierengarten$5033.4% downsideOpen
2025-10-29Goldman Sachs$5526.7% downsideOpen
2025-10-13Wedbush$4441.4% downsideOpen
2025-07-29Jefferies$5428.1% downsideOpen
2024-10-29Evercore ISILiisa Bayko$3553.4% downsideOpen
2024-09-13JefferiesRoger Song$4046.7% downsideOpen
2024-05-03Wells FargoEva Fortea Verdejo$3454.7% downsideOpen

Kiniksa Pharmaceuticals International Plc. (KNSA) FAQ

As of the most recent data, KNSA shows a target price of $85. Scroll down for historical charts and peer comparison views.

If Kiniksa Pharmaceuticals International Plc. moved to the average analyst target of $85, shares would be roughly 12.8% higher than $75.08. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Kiniksa Pharmaceuticals International Plc.'s earnings trajectory.

Besides this target price page, Stockcircle has Kiniksa Pharmaceuticals International Plc.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $85) with ownership activity and broader fundamentals.

Kiniksa Pharmaceuticals International Plc.'s target price is $85; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.